Q1 2026 Management View "During the first quarter, we reached an agreement to divest certain GI products. And in April, we reached a second agreement to divest our remaining GI products." (President, ...
Zacks Investment Research on MSN
CONMED's Q1 earnings and revenues beat, organic sales outlook up
CONMED Corporation CNMD posted adjusted earnings per share (EPS) of 89 cents for the first quarter of 2026, down 6.3% year ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
An executive shuffle at Conmed Corp. is unlikely to impact day-to-day operations at ConMed Linvatec, the largest medical technology company in Tampa Bay. An executive shuffle at Conmed Corp. is ...
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2022 after the market close on Wednesday, April 27, 2022. The ...
The multi-year agreements are with CONMED’s Linvatec and Endoscopic Technologies. Products covered in the agreements include CONMED’s advanced endoscopic imaging products, Enteral Feeding systems and ...
We think that DENTSPLY stock (NASDAQ NDAQ: XRAY), a dental equipment company, is currently a better pick than ConMed (NASDAQ: CNMD), a medical devices company that specializes in products for ...
HANOVER, Md.--(BUSINESS WIRE)-- Conmed Healthcare Management, Inc. (NYSE Amex: CONM) (“Conmed” or the “Company”), a leading full service provider of correctional facility healthcare services to county ...
The CEO is out at ConMed Corp., the parent company of the largest medical technology firm in Tampa Bay. The CEO is out at ConMed Corp., the parent company of the largest medical technology firm in ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
WALTHAM, Mass.--(BUSINESS WIRE)--Medical Capital Advisors, a specialized mergers and acquisitions consulting firm focused solely on the medical technology industry, today announced that it advised The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results